Skip to main content
. 2018 Jun 23;33:169–184. doi: 10.1016/j.ebiom.2018.06.015

Fig. 1.

Fig. 1

Three-step biomarker discovery workflow. Starting with an initial pool of over 13,000 markers, a series of statistical comparisons between ALS and healthy controls samples refined the final ALS chromosome conformation signature panel into a set of 8 markers that could diagnose ALS patients in a blinded, independent cohort with 87.5% sensitivity.